Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 11Terminated 3

Sponsor Class

OTHER 8INDUSTRY 7NETWORK 3NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1

Conditions

Lymphoma 2Hodgkin Disease 2Sarcoma 1

Interventions

Radiotherapy 41Cisplatin 36Fluorouracil 17Paclitaxel 15Docetaxel 14Cyclophosphamide 14Carboplatin 14Filgrastim 13Doxorubicin 13Gemcitabine 11Etoposide 11Capecitabine 10Surgical Procedures, Operative 9Methotrexate 9Leucovorin 9Chemotherapy, Adjuvant 9Vincristine 8Peripheral Blood Stem Cell Transplantation 8Oxaliplatin 8Dexamethasone 7Bevacizumab 7Topotecan 6Radiotherapy, Conformal 6Prednisone 6Fenretinide 6Cetuximab 6Neoadjuvant Therapy 5Mitomycin 5Irinotecan 5Ifosfamide 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × NETWORK × Dacarbazine × Clear all
NCT01390584 2023-06-29

Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma

Eastern Cooperative Oncology Group

Phase 2 Terminated
6 enrolled 9 charts
Lymphoid

Hodgkin Disease, Lymphoma

NCT00033644 2013-04-11

Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus

GOG Foundation

Phase 2 Terminated
Sarcoma

Sarcoma

NCT00005090 2013-01-24

S9901 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Men With Stage III or Stage IV Hodgkin's Disease

SWOG Cancer Research Network

Phase 3 Terminated
11 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡